Focus
Access across the healthcare and life-sciences ecosystem
The most important healthcare opportunities rarely fit within a single advisory discipline. Scientific evidence, clinical adoption, regulation, commercial strategy and capital often need to advance together.
ManaraMED works across these connected priorities, with the scope of each engagement shaped around the client's objective.
Healthcare and life-sciences companies often enter the Gulf without a clear sense of which investors are genuinely relevant. Capital in the region is shaped not only by financial fundamentals, but also by relationships, sector understanding and regional judgement.
ManaraMED helps companies assess investment readiness, shape their capital strategy and engage investors where there is genuine fit. For investors, we bring clinical and commercial judgement to the assessment of opportunities and, where appropriate, may participate alongside our network. Investment is considered as part of the broader strategic opportunity rather than as a standalone fundraising exercise.
Clinical development in a new region requires more than regulatory knowledge. It depends on feasibility, institutional capability and the right clinical and operational relationships.
ManaraMED helps clients assess whether the GCC is the right setting for a programme, identify and engage hospitals, investigators and specialist partners, and coordinate the regulatory, operational and supporting workstreams required to move a programme forward. Our leadership’s direct experience in clinical medicine, hospital management and the regional research ecosystem provides practical insight into how research is established and conducted in the region.
Regulatory approval alone does not create a market. Successful access in the GCC depends on understanding how decisions are made, how institutions procure and which stakeholders influence adoption.
ManaraMED helps clients assess the commercial opportunity, prioritise markets, define the right route to market and align regulatory, access, procurement and launch strategy with the realities of the region.
For many companies, the question is not whether there is demand in the GCC, but how to enter the market and with whom. The right partner can accelerate expansion; the wrong one can restrict it for years.
ManaraMED helps clients identify, evaluate and establish the commercial and strategic partnerships required for regional growth. We remain involved through structuring and negotiation, supporting distribution, licensing, alliances, market entry and broader GCC expansion.
Healthcare providers face strategic choices around growth, new clinical programmes, partnerships, technology adoption and performance improvement.
ManaraMED advises on strategy, clinical and operational development and expansion, working alongside clinical and executive leadership to ensure that strategy is grounded in how healthcare is actually delivered. Our team’s experience within hospital medicine and management brings a practical perspective to institutional development and growth.
Healthcare innovation creates value when it addresses a genuine clinical, operational or economic need and can be adopted within the realities of healthcare delivery. ManaraMED works with innovators and healthcare providers to assess that fit, define the path to adoption and build the partnerships required to move from potential to implementation.
We support market entry, clinical validation, pilot development, regulatory and procurement strategy and access to relevant healthcare institutions. For providers, we help identify and assess technologies, evaluate relevant use cases and develop clinical validation and strategic innovation partnerships.
Some international companies have significant ambitions in the GCC but are not yet ready to establish a full regional organisation. In these cases, consistent senior presence and well-managed relationships can be critical to building momentum.
For a selected number of clients, ManaraMED acts as an ongoing strategic regional partner, representing their interests, developing key relationships and identifying and qualifying opportunities. The mandate can include regional strategy, business development, institutional engagement, negotiation support and ongoing market intelligence as the client’s own regional presence develops.
One objective may require several capabilities.
A clinical programme can lead to hospital partnerships and commercial expansion. A technology pilot can create an investment opportunity. An acquisition can require a new regional strategy.
ManaraMED connects the workstreams so clients do not have to coordinate multiple disconnected advisors.
Discuss an objectiveContact
Start a conversation
For enquiries concerning healthcare, life sciences or investment in the GCC.
ManaraMED L.L.C-FZ
Meydan Grandstand, 6th Floor
Meydan Road, Nad Al Sheba
Dubai, United Arab Emirates
ManaraMED LLC
16192 Coastal Hwy
Lewes, DE 19958
United States
Our team works in English, Arabic, German, Portuguese, Spanish, Italian, French and Aramaic.